Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Gross Profit 2011-2025 | ZTS

Zoetis annual/quarterly gross profit history and growth rate from 2011 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Zoetis gross profit for the quarter ending March 31, 2025 was $1.598B, a 3.3% increase year-over-year.
  • Zoetis gross profit for the twelve months ending March 31, 2025 was $6.588B, a 7.68% increase year-over-year.
  • Zoetis annual gross profit for 2024 was $6.537B, a 9.26% increase from 2023.
  • Zoetis annual gross profit for 2023 was $5.983B, a 6.35% increase from 2022.
  • Zoetis annual gross profit for 2022 was $5.626B, a 2.8% increase from 2021.
  
Zoetis Annual Gross Profit
(Millions of US $)
2024 $6,537
2023 $5,983
2022 $5,626
2021 $5,473
2020 $4,618
2019 $4,268
2018 $3,914
2017 $3,532
2016 $3,222
2015 $3,027
2014 $3,068
2013 $2,892
2012 $2,773
2011 $2,581
2010 $2,138
Zoetis Quarterly Gross Profit
(Millions of US $)
2025-03-31 $1,598
2024-12-31 $1,610
2024-09-30 $1,687
2024-06-30 $1,693
2024-03-31 $1,547
2023-12-31 $1,485
2023-09-30 $1,513
2023-06-30 $1,573
2023-03-31 $1,412
2022-12-31 $1,387
2022-09-30 $1,395
2022-06-30 $1,427
2022-03-31 $1,417
2021-12-31 $1,367
2021-09-30 $1,404
2021-06-30 $1,380
2021-03-31 $1,322
2020-12-31 $1,206
2020-09-30 $1,240
2020-06-30 $1,097
2020-03-31 $1,075
2019-12-31 $1,144
2019-09-30 $1,105
2019-06-30 $1,082
2019-03-31 $937
2018-12-31 $1,020
2018-09-30 $1,007
2018-06-30 $968
2018-03-31 $919
2017-12-31 $1,003
2017-09-30 $912
2017-06-30 $829
2017-03-31 $788
2016-12-31 $809
2016-09-30 $831
2016-06-30 $809
2016-03-31 $773
2015-12-31 $778
2015-09-30 $793
2015-06-30 $748
2015-03-31 $708
2014-12-31 $829
2014-09-30 $776
2014-06-30 $745
2014-03-31 $718
2013-12-31 $788
2013-09-30 $718
2013-06-30 $698
2013-03-31 $688
2012-12-31 $743
2012-09-30 $660
2012-06-30 $716
2012-03-31 $654
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $72.987B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.021B 32.64
Daiichi Sankyo, - (DSNKY) Japan $49.540B 25.20
Takeda Pharmaceutical (TAK) Japan $45.278B 9.01
Sandoz Group AG (SDZNY) Switzerland $20.747B 0.00
Summit Therapeutics (SMMT) United States $17.831B 0.00
Merck (MKKGY) Germany $16.820B 12.32
United Therapeutics (UTHR) United States $13.772B 12.18
Shionogi (SGIOY) Japan $13.084B 13.11
Neurocrine Biosciences (NBIX) United States $12.155B 41.63
IPSEN (IPSEY) France $9.731B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $7.934B 64.50
Stevanato Group S.p.A (STVN) Italy $7.504B 45.89
Madrigal Pharmaceuticals (MDGL) United States $6.455B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.500B 0.00
Ionis Pharmaceuticals (IONS) United States $5.416B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 15.33
Soleno Therapeutics (SLNO) United States $3.809B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.004B 10.53
Crinetics Pharmaceuticals (CRNX) United States $2.898B 0.00
Hypermarcas (HYPMY) Brazil $2.755B 18.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.351B 12.71
BioCryst Pharmaceuticals (BCRX) United States $2.170B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.090B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.833B 0.00
Guardian Pharmacy Services (GRDN) United States $1.678B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.638B 0.00
Indivior (INDV) United States $1.610B 6.83
Evotec AG (EVO) Germany $1.410B 0.00
ARS Pharmaceuticals (SPRY) United States $1.401B 0.00
Dyne Therapeutics (DYN) United States $1.325B 0.00
Ocular Therapeutix (OCUL) United States $1.196B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.090B 21.81
Harrow (HROW) United States $1.038B 0.00
Ardelyx (ARDX) United States $0.971B 0.00
Collegium Pharmaceutical (COLL) United States $0.958B 5.17
Avadel Pharmaceuticals (AVDL) Ireland $0.905B 0.00
Enliven Therapeutics (ELVN) United States $0.827B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
Xeris Biopharma Holdings (XERS) United States $0.762B 0.00
Akebia Therapeutics (AKBA) United States $0.735B 0.00
AleAnna (ANNA) United States $0.667B 0.00
KalVista Pharmaceuticals (KALV) United States $0.600B 0.00
Xencor (XNCR) United States $0.574B 0.00
Bioventus (BVS) United States $0.569B 14.44
USANA Health Sciences (USNA) United States $0.560B 12.17
Elite Pharmaceuticals (ELTP) United States $0.552B 0.00
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Savara (SVRA) United States $0.541B 0.00
Relay Therapeutics (RLAY) United States $0.502B 0.00
Zevra Therapeutics (ZVRA) United States $0.487B 0.00
CytoDyn (CYDY) United States $0.481B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.478B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.470B 0.00
Altimmune (ALT) United States $0.446B 0.00
Siga Technologies (SIGA) United States $0.433B 9.05
Tourmaline Bio (TRML) United States $0.427B 0.00
Organogenesis (ORGO) United States $0.410B 0.00
Verve Therapeutics (VERV) United States $0.390B 0.00
Oruka Therapeutics (ORKA) United States $0.386B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.352B 9.52
Heron Therapeutics (HRTX) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.22
Aquestive Therapeutics (AQST) United States $0.243B 0.00
ProKidney (PROK) United States $0.237B 0.00
MediWound (MDWD) Israel $0.222B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.195B 0.00
Wellgistics Health (WGRX) United States $0.193B 0.00
OmniAb (OABI) United States $0.189B 0.00
Nanobiotix S.A (NBTX) France $0.186B 0.00
Avita Medical (RCEL) United States $0.178B 0.00
4D Molecular Therapeutics (FDMT) United States $0.176B 0.00
Esperion Therapeutics (ESPR) United States $0.171B 0.00
Liminatus Pharma (LIMN) $0.164B 0.00
Journey Medical (DERM) United States $0.156B 0.00
Profound Medical (PROF) Canada $0.150B 0.00
Korro Bio (KRRO) United States $0.148B 0.00
Aldeyra Therapeutics (ALDX) United States $0.145B 0.00
Aclaris Therapeutics (ACRS) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.132B 0.00
Nektar Therapeutics (NKTR) United States $0.129B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.127B 0.00
Larimar Therapeutics (LRMR) United States $0.125B 0.00
Lyell Immunopharma (LYEL) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Achieve Life Sciences (ACHV) Canada $0.115B 0.00
VAXART, INC (VXRT) United States $0.114B 0.00
Lexeo Therapeutics (LXEO) United States $0.109B 0.00
Fractyl Health (GUTS) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.099B 0.00
OptiNose (OPTN) United States $0.098B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.082B 13.45
Cumberland Pharmaceuticals (CPIX) United States $0.082B 60.56
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Inotiv (NOTV) United States $0.077B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Unicycive Therapeutics (UNCY) United States $0.073B 0.00
Surrozen (SRZN) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Mural Oncology (MURA) Ireland $0.048B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
Karyopharm Therapeutics (KPTI) United States $0.044B 0.00
Avalo Therapeutics (AVTX) United States $0.043B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Mannatech (MTEX) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Relmada Therapeutics (RLMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.77
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00